Ardelyx Inc. | Key People and Executives
Michael G. Raab
President, Chief Executive Officer & Director
Jan M. Lundberg
Independent Director
Annalisa Mary Jenkins
Independent Non-Executive Director
Robert B. Bazemore
Independent Director
Gordon Ringold
Independent Director
William C. Bertrand
Independent Director
Richard J. Rodgers
Independent Director
Michael G. Raab
President, Chief Executive Officer & Director
Mark E. Kaufmann
Chief Financial & Accounting Officer, Treasurer
Jeffrey W. Jacobs
Senior Vice President-Technical Operations
David P. Rosenbaum
Chief Development Officer
Robert C. Blanks
Senior VP-Regulatory Affairs & Quality Assurance
Elizabeth Grammer
Executive Vice President & General Counsel
Jan M. Lundberg
Independent Director
Annalisa Mary Jenkins
Independent Non-Executive Director
Robert B. Bazemore
Independent Director
Gordon Ringold
Independent Director
William C. Bertrand
Independent Director
Richard J. Rodgers
Independent Director
| Address |
34175 Ardenwood Boulevard
Fremont California 94555
United States
|
|
Employees
|
- |
| Website |
http://www.ardelyx.com |
| Updated |
07/08/2019 |
| Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicine for the treatment of renal diseases. It also focuses on the development of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. |
